Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar jchoover (94.71) Submitted: 12/23/2009 5:30:42 PM : Outperform Start Price: $28.95 ONXX Score: +42.39

porte

Featured Broker Partners


Advertisement